BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Merck and Mycenax Biotech Forge Partnership for Bioprocessing Innovation

Merck announces a non-binding MoU with Mycenax Biotech to optimize bioprocessing production of life-changing biological therapies Integrates company&rsq...

January 24, 2024 | News

Merck's JAVELIN Bladder Regimen Shines in Real-World Data, Elevating Standard Care for Urothelial Carcinoma

Merck, a distinguished science and technology company, has announced groundbreaking real-world data that further solidify the JAVELIN Bladder regimen as a ...

January 23, 2024 | News

Thermo Fisher's RNA Facility in Monza, Italy, Gains GMP Approval from Italian Medicines Agency (AIFA)

Thermo Fisher Scientific, the world leader in serving science, has received Good Manufacturing Practice (GMP) approval from the Italian Medicines Agency (A...

January 19, 2024 | News

Geneoscopy Challenges Exact Sciences’ Patent with Inter Partes Review Petition

Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced that it ha...

January 15, 2024 | News

Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna

First-in-class ompenaclid (RGX-202) currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer Collaboration includes ex...

January 09, 2024 | News

Beckman Coulter Launches Groundbreaking Anti-TRBC2 Conjugated Antibody for Flow Cytometry

Traditional approaches to identify clonal T-cell expansion have been complex and challenging, relying on the assessment of abnormal antigen expression, whi...

January 09, 2024 | News

GenScript, GenScript ProBio, and Legend Biotech to Showcase Innovations at 42nd JPM Healthcare Conference

This initiative aims to showcase GenScript's exceptional strength and development potential in the biotech sector, seeking to establish deeper interactions...

January 05, 2024 | News

Merck Broadens Colorectal Cancer Portfolio via Licensing Deal with Inspirna

First-in-class ompenaclid (RGX-202) currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer Collaboration includes ex...

January 05, 2024 | News

Thermo Fisher Introduces PangenomiX Array for Large-Scale Disease and Pharmacogenomics Research

Earlier this year, scientists unveiled the first draft of the pangenome, based on full genetic blueprints from 47 people around the world to create a more ...

January 05, 2024 | News

Allorion Therapeutics and AstraZeneca Ink Exclusive Deal for EGFR L858R Inhibitor Program

Under the terms of the agreement, AstraZeneca will be granted an exclusive option to license a novel EGFR L858R allosteric inhibitor to develop and co...

January 03, 2024 | News

Agilent Technologies Consolidates Cell Analysis Division into Diagnostics and Genomics Group for Strategic Growth

Agilent Technologies Inc. (NYSE: A) announced it has moved the company's Cell Analysis Division into its Diagnostics and Genomics Group (DGG) a...

January 02, 2024 | News

HeraNova Lifesciences Raises $13.5M in Seed Funding for Women's Health Solutions

Heranova Lifesciences Holding Ltd. ("Heranova") announced the successful completion of a USD 13.5 million seed and seed+ financing to devel...

December 29, 2023 | News

Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024

Unveiling the Pioneering Companies Poised to Transform Healthcare 1. QuantumGen Website: quantumgen.com Location: San Francisco, CA, USA Focu...

December 29, 2023 | News

2024 GenScript Biotech Global Forum to Propel Cell and Gene Therapy Innovations

The innovative development of biopharmaceuticals has ushered in a new era for disease treatment, bringing unprecedented hope to countless patients. However...

December 26, 2023 | News

Stay Connected